$CTM

Ives Glen R purchased $910 of CTM

Ives Glen R (President) purchased 1,700 shares of Castellum, Inc. (CTM) at $0.54 on 2026-10-01.

Original reporting
SEC EDGAR · Ives Glen R
Published Oct 1, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 8:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CTM
Neutral
high confidence
Mentioned
$CTM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTMNeutralLow
01

Why it matters

The filing provides a fresh data point on insider activity but is unlikely to move the stock materially.

02

Market read

A routine insider purchase with limited trading relevance.

03

What to watch

The transaction size is tiny compared with total holdings; market may ignore it.

Relevance 4/10Novelty 3/10Timing: today

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$CTMNeutralHigh confidence
Context

President Ives Glen R bought 1,700 shares of Castellum, Inc. for $909.84 in an open‑market purchase.

Expected impact

slight upward pressure as market prices in the insider buy

Evidence & confidence

Purchase size is modest relative to float; typical insider buys have limited short‑term effect.

Market effects

Minimal effect on REIT sector; insider activity is routine.

No broader regional impact.

Not globally relevant.

Counterpoint

The purchase could be a window‑dressing move rather than a genuine confidence signal.

Key entities

  • Castellum, Inc.

    US‑listed REIT focused on commercial real estate.

  • Ives Glen R.

    President of Castellum, Inc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTMMed

Castellum Q2 Earnings Call Highlights

Castellum reported Q2 backlog of $271.7M and a qualified pipeline of $953.5M. CFO David Bell said at least 16% of June 30 backlog is expected to be recognized over 12 months and about 48% over 36 months, noting government funding timing. The CTM venture won a Navy Logistics IT Integration contract (max ~$250M). Gross profit fell to $4.7M (34% of revenue). Net loss was $1.0M.

$CTMMed

Canterra Minerals Commences Phase 2 Drill Program to Advance District-Scale Copper-Zinc Growth Strategy at Buchans, Newfoundland

Canterra Minerals (TSXV: CTM, OTCQB: CTMCF, FSE: DXZB) started an ~8,000 m Phase 2 diamond drill program at its Buchans copper-zinc district in Newfoundland, including ~2,000 m at the Lundberg deposit. The company aims to support a maiden Lundberg mineral resource estimate targeted for Q4 2026 and test satellite targets. It also reported ~$1.13M from warrant and option exercises.

$CTMMedAI 8/10

CTM uncovers Australian revenue errors dating back to 2019, delays financial statements

Corporate Travel Management (CTM) said in an ASX update that it has delayed lodgement of its overdue FY25 and first-half FY26 financial statements to August 2026. The audit found new issues: CTM expects to restate ANZ FY24 revenue by $10–15m, mainly from FY19–FY23 rebate accounting, and identified UK air booking margin contracts needing further review. CTM also disclosed goodwill impairments (GBP 92m Europe, AUD 77m ANZ, USD 49m North America) and ongoing lender discussions tied to a UK £118m ov